EFDID: 261495EFD: View Filing

Issuer: Tracon Pharmaceuticals, Inc. (0001394319) - D

Accession: 0001631338-18-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001394319
  • Entity Name:
    Tracon Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    4350 LA JOLLA VILLAGE DRIVE
    SUITE 800
    San Diego, CA 92122
  • Persons:
    Related Persons 8
    CHARLES P. THEUER
    Executive Officer, Director
    PATRICIA L. BITAR
    Executive Officer
    WILLIAM LARUE
    Director
    MARTIN MATTINGLY
    Director
    J. RAINER TWIFORD
    Director
    PAUL WALKER
    Director
    STEPHEN WORLAND
    Director
    TED WANG
    Director
EDGAR: Offering Information
  • Accession Date:
    04/10/2018
  • First Sale Date:
    03/27/2018
  • Offering Amount:
    $75,670,770
  • Amount Sold:
    $38,673,734
  • Amount Remaining:
    $36,997,036
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    "Total Offering Amount" includes amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's Common Stock (assuming no cashless exercise).
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
LifeSci Capital 168404 None None All States
Angel Pond Capital LLC 287761 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Tracon Pharmaceuticals, Inc.Patricia L. BitarPatricia L. BitarCFO2018-04-10